Brian T. Rekoske

625 total citations
10 papers, 471 citations indexed

About

Brian T. Rekoske is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Brian T. Rekoske has authored 10 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Brian T. Rekoske's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (3 papers). Brian T. Rekoske is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers) and CAR-T cell therapy research (3 papers). Brian T. Rekoske collaborates with scholars based in United States, France and China. Brian T. Rekoske's co-authors include Douglas G. McNeel, Weibo Cai, Brian M. Olson, Todd E. Barnhart, Emily B. Ehlerding, Reinier Hernandez, Christopher G. England, Glenn Liu, Heath A. Smith and Stephen A. Graves and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Bacteriology.

In The Last Decade

Brian T. Rekoske

10 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian T. Rekoske United States 8 292 205 138 118 89 10 471
Olga Blomberg Netherlands 9 293 1.0× 303 1.5× 140 1.0× 181 1.5× 42 0.5× 9 583
Dries Renmans Belgium 8 244 0.8× 296 1.4× 70 0.5× 253 2.1× 34 0.4× 9 500
Camille M. Le Gall Netherlands 6 281 1.0× 275 1.3× 157 1.1× 133 1.1× 24 0.3× 10 457
Anne Mobergslien Norway 12 134 0.5× 179 0.9× 124 0.9× 204 1.7× 67 0.8× 18 480
Zea Melton United States 7 165 0.6× 120 0.6× 66 0.5× 113 1.0× 22 0.2× 8 288
Midori Isobe Japan 13 337 1.2× 501 2.4× 63 0.5× 179 1.5× 38 0.4× 27 660
Sofie Denies Belgium 8 108 0.4× 122 0.6× 110 0.8× 119 1.0× 37 0.4× 15 293
Frans V. Suurs Netherlands 7 207 0.7× 120 0.6× 204 1.5× 112 0.9× 21 0.2× 11 363
Kasper Mølgaard Denmark 8 233 0.8× 173 0.8× 120 0.9× 118 1.0× 15 0.2× 10 347
J Filderman United States 5 234 0.8× 411 2.0× 87 0.6× 191 1.6× 17 0.2× 7 532

Countries citing papers authored by Brian T. Rekoske

Since Specialization
Citations

This map shows the geographic impact of Brian T. Rekoske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian T. Rekoske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian T. Rekoske more than expected).

Fields of papers citing papers by Brian T. Rekoske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian T. Rekoske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian T. Rekoske. The network helps show where Brian T. Rekoske may publish in the future.

Co-authorship network of co-authors of Brian T. Rekoske

This figure shows the co-authorship network connecting the top 25 collaborators of Brian T. Rekoske. A scholar is included among the top collaborators of Brian T. Rekoske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian T. Rekoske. Brian T. Rekoske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
McNeel, Douglas G., Jens C. Eickhoff, Robert Jeraj, et al.. (2017). DNA vaccine with pembrolizumab to elicit antitumor responses in patients with metastatic, castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(7_suppl). 168–168. 10 indexed citations
2.
England, Christopher G., Dawei Jiang, Emily B. Ehlerding, et al.. (2017). 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 45(1). 110–120. 101 indexed citations
3.
Olson, Brian M., Weixiong Zhong, Erik A. Ranheim, et al.. (2017). Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand‐Binding Domain (AR‐LBD). The Prostate. 77(7). 812–821. 7 indexed citations
4.
Rekoske, Brian T., Brian M. Olson, & Douglas G. McNeel. (2016). Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses. OncoImmunology. 5(6). e1165377–e1165377. 40 indexed citations
5.
England, Christopher G., Emily B. Ehlerding, Reinier Hernandez, et al.. (2016). Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab. Journal of Nuclear Medicine. 58(1). 162–168. 156 indexed citations
6.
Rekoske, Brian T. & Douglas G. McNeel. (2016). Immunotherapy for prostate cancer: False promises or true hope?. Cancer. 122(23). 3598–3607. 21 indexed citations
7.
Rekoske, Brian T., Heath A. Smith, Brian M. Olson, Brett Maricque, & Douglas G. McNeel. (2015). PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope–Modified DNA Vaccine Immunization. Cancer Immunology Research. 3(8). 946–955. 59 indexed citations
8.
Smith, Heath A., Brian T. Rekoske, & Douglas G. McNeel. (2014). DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses. Vaccine. 32(15). 1707–1715. 14 indexed citations
9.
Rekoske, Brian T., Heath A. Smith, & Douglas G. McNeel. (2013). Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells. Journal for ImmunoTherapy of Cancer. 1(S1). 2 indexed citations
10.
My, Lætitia, Brian T. Rekoske, Justin J. Lemke, et al.. (2013). Transcription of the Escherichia coli Fatty Acid Synthesis OperonfabHDGIs Directly Activated by FadR and Inhibited by ppGpp. Journal of Bacteriology. 195(16). 3784–3795. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Blomberg Breakdown of academic impact, for papers by Dries Renmans Breakdown of academic impact, for papers by Camille M. Le Gall Breakdown of academic impact, for papers by Anne Mobergslien Breakdown of academic impact, for papers by Zea Melton Breakdown of academic impact, for papers by Midori Isobe Breakdown of academic impact, for papers by Sofie Denies Breakdown of academic impact, for papers by Frans V. Suurs Breakdown of academic impact, for papers by Kasper Mølgaard Breakdown of academic impact, for papers by J Filderman
Rankless by CCL
2026